2017 American Transplant Congress » Concurrent Session: Islet Transplant

4:30pm-4:42pm

Bioengineering Human Islets to Form Peri-Islet Vessels from Intraislet Endothelial Cells for Improving Human Islet Function.

G. Loganathan, S. Narayanan, M. Dhanasekaran, A. Patel, W. Tucker, M. Hughes, S. Williams, A. Balamurugan.

4:42pm-4:54pm

Islet Rejection in Autoimmune NOD Mouse Recipients: Implications for Stem Cell Therapies.

R. Gill,¹ M. Coulombe,¹ T. Kupfer,¹ K. Beard,¹ A. Burrack.²

4:54pm-5:06pm

IgM Immunotherapy Restores Immune Homeostasis in Type 1 Diabetes.

P. Chhabra,¹ C. Wilson,² D. Moore,² K. Brayman.¹

5:06pm-5:18pm

Long-Term Drug-Free Survival of Tiny Cynomolgus Islet Allografts.

M. Koulmanda, V. Chipashivili, M. Duggan, T. Strom.

5:18pm-5:30pm

A Combination of Anti-CD40L-Ab, Rapamycin, and Donor Apoptotic Cells Prolongs Allogeneic Pancreatic Islet Survival in Sensitized Mice by Regulating Memory Responses.

A. Dangi,¹ H.-K. Kang,¹ X. Zhang,^2,3 X. Luo.^1,2,3

5:30pm-5:42pm

Optimization of Pancreatic Islet-Like Clusters from hiPSCs for Cell Therapy in Type 1 Diabetes.

G. Pettinato, P. Kyriazis, M. Thompson, M. Koulmanda, R. Fisher.

5:42pm-5:54pm

Inhibition of Liver Natural Killer Cells Activation Through Co-Transplantation of Pre-Activated Mesenchymal Stem Cells Contributes to Improvement of Islet Graft Survival.

N. Ishida, K. Ishiyama, Y. Saeki, Y. Tanaka, H. Ohdan.